# "AIDA" Protocol (LAP 0493)

> **NCT01064557** · NA · UNKNOWN · sponsor: **Gruppo Italiano Malattie EMatologiche dell'Adulto** · enrollment: 1068 (estimated)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** all-trans retinoic acid (ATRA)

## Key facts

- **NCT ID:** NCT01064557
- **Lead sponsor:** Gruppo Italiano Malattie EMatologiche dell'Adulto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1993-10
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 1068 (ESTIMATED)
- **Last updated:** 2020-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01064557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01064557, ""AIDA" Protocol (LAP 0493)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01064557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*